ARCHIVES

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Price Increase

July 22, 1983

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Letter to the Editor

February 21, 2003